TheraVet (ISIN: BE0974387194 - ticker: ALVET) today announces a strategic transformation project with H4Orphan aimed at ...

Aug. 22, 2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying molecule is as sneaky as its inventors ... COPD and BPD ...

If you experience any of the following symptoms, seek immediate medical attention to rule out more serious possible causes of your pain like a heart attack or pulmonary embolism: Heartburn, acid ...

Insilico Medicine has announced positive preliminary results from its Phase IIa clinical trial of ISM001-055, a small ...

This blog describes a typical ILD patient journey from the initial diagnosis through its long-term management to end-of-life ...

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the ...

To manage acid reflux and stomach ulcers, consider adding alkaline foods like bananas, cucumbers, and avocados to your diet. These foods help neutralize stomach acid, reduce inflammation ...

Although you may have been diagnosed with gastroesophageal reflux disease (GERD), that doesn't mean you can't enjoy your life to its fullest. There are ways to control GERD that won't necessarily make ...

Background A usual interstitial pneumonia (UIP) pattern of lung injury is a key feature of idiopathic pulmonary fibrosis (IPF) and is also observed in up to 40% of individuals with rheumatoid ...

Roivant has acquired from Bayer, the German pharma company, an experimental drug called mosliciguat that will be developed as a treatment for certain types of pulmonary hypertension, a family of ...

Garadacimab is under clinical development by CSL and currently in Phase II for Idiopathic Pulmonary Fibrosis. According to GlobalData, Phase II drugs for Idiopathic Pulmonary Fibrosis have a 35% phase ...